Skip to main content

Published locations for FDA approves idelalisib for three leukemia and lymphoma indications

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves idelalisib for three leukemia and lymphoma indications

User login

  • Reset your password
  • /content/fda-approves-idelalisib-three-leukemia-and-lymphoma-indications
  • /oncologypractice/article/85993/lymphoma-plasma-cell-disorders/fda-approves-idelalisib-three-leukemia
  • /hematology-oncology/article/85993/lymphoma-plasma-cell-disorders/fda-approves-idelalisib-three
  • /b-cell-lymphoma-icymi/article/85993/lymphoma-plasma-cell-disorders/fda-approves-idelalisib-three